The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
N-(1,3-dioxo-1H-benzo[de]isoquinolin-2(3H)-yl)-2-(4-methylpiperidin-1-yl)acetamide ID: ALA4087137
PubChem CID: 39070423
Max Phase: Preclinical
Molecular Formula: C20H21N3O3
Molecular Weight: 351.41
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: CC1CCN(CC(=O)NN2C(=O)c3cccc4cccc(c34)C2=O)CC1
Standard InChI: InChI=1S/C20H21N3O3/c1-13-8-10-22(11-9-13)12-17(24)21-23-19(25)15-6-2-4-14-5-3-7-16(18(14)15)20(23)26/h2-7,13H,8-12H2,1H3,(H,21,24)
Standard InChI Key: MEXGQNLBAWNRDM-UHFFFAOYSA-N
Molfile:
RDKit 2D
26 29 0 0 0 0 0 0 0 0999 V2000
39.8470 -1.3908 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
39.8458 -2.2145 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
40.5562 -0.9820 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
41.2648 -1.3872 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
42.6906 -2.2066 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
42.6859 -1.3804 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
41.9727 -0.9770 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
41.2656 -2.2104 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
40.5584 -2.6225 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
40.5582 -3.4385 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
41.2634 -3.8486 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
41.9747 -3.4406 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
41.9766 -2.6184 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
39.8456 -3.8459 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
42.6860 -3.8501 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
41.2620 -4.6699 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
41.9732 -5.0838 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
41.9718 -5.9051 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
42.6857 -4.6723 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
42.6829 -6.3149 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
42.6760 -7.1369 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
43.3831 -7.5507 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
44.0980 -7.1427 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
44.1014 -6.3204 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
43.3898 -5.9062 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
44.8076 -7.5593 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 9 1 0
4 3 2 0
3 1 1 0
4 8 1 0
13 5 2 0
5 6 1 0
6 7 2 0
7 4 1 0
8 9 2 0
8 13 1 0
9 10 1 0
10 11 1 0
11 12 1 0
12 13 1 0
10 14 2 0
12 15 2 0
11 16 1 0
16 17 1 0
17 18 1 0
17 19 2 0
18 20 1 0
20 21 1 0
20 25 1 0
21 22 1 0
22 23 1 0
23 24 1 0
24 25 1 0
23 26 1 0
M END Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 351.41Molecular Weight (Monoisotopic): 351.1583AlogP: 2.20#Rotatable Bonds: 3Polar Surface Area: 69.72Molecular Species: NEUTRALHBA: 4HBD: 1#RO5 Violations: ┄HBA (Lipinski): 6HBD (Lipinski): 1#RO5 Violations (Lipinski): ┄CX Acidic pKa: 9.78CX Basic pKa: 6.89CX LogP: 2.12CX LogD: 2.00Aromatic Rings: 2Heavy Atoms: 26QED Weighted: 0.86Np Likeness Score: -1.22
References 1. Klimenko K, Lyakhov S, Shibinskaya M, Karpenko A, Marcou G, Horvath D, Zenkova M, Goncharova E, Amirkhanov R, Krysko A, Andronati S, Levandovskiy I, Polishchuk P, Kuz'min V, Varnek A.. (2017) Virtual screening, synthesis and biological evaluation of DNA intercalating antiviral agents., 27 (16): [PMID:28666733 ] [10.1016/j.bmcl.2017.06.035 ]